In acquiring Mayne Pharma’s U.S. portfolio, Dr. Reddy’s gains a birth control pill whose rapid sales growth is attributed to a direct-to-consumer marketing strategy. The deal also includes pipeline products and approved products that are not yet on the market.
The wet form of age-related macular degeneration (AMD) is currently treated with eye drugs that are blockbuster sellers. Opthea Limited is developing a wet AMD drug that goes after different targets and the biotech struck a pair of financing deals that provide it with the cash for pivotal tests that could show how well its approach works.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
CSL Limited makes many of its therapies from donated plasma, which posed a challenge as pandemic lockdowns led to a steep drop in plasma collections. In acquiring Vifor Pharma, CSL not only diversifies, it also expands its presence in the fast-growing nephrology market.
Ellume, a startup that won a $232 million contract to manufacture more of its over-the-counter Covid-19 tests in the U.S., has started building a manufacturing facility in Maryland. In the longer term, it plans to use the site to prepare for future outbreaks and pandemics.
After European regulators signed off on the deal, Australian regulators rejected a proposal by Google to assuage concerns about its proposed acquisition of Fitbit. They will continue their investigation of the merger through the end of March.
A review published in JAMA found that bills introduced into the House and Senate don't go nearly as far as existing drug pricing regulations other countries. The researchers listed eight key lessons from six nations.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
In line with the persistent shift to remote medicine, we are seeing innovation happening in more distributed medical technology regions.
The agency approved Scenesse, a subcutaneous implant for treating the rare disorder erythropoietic protoporphyria. The drug is the first FDA-approved treatment for EPP.
Drug regulators in the U.S., Canada and Australia simultaneously approved Merck's Keytruda and Eisai's Lenvima for advanced endometrial carcinoma following a collaborative review under a program called Project Orbis.
In a Q&A with diagnostics service provider Invetech, President Andreas Knaack talked about some of the evolving healthcare trends that diagnostics companies face, particularly the rise of decentralized healthcare, the aging baby boomer generation and with it, the rise of chronic diseases.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Rep. Christopher Collins of New York had suspended his campaign after his indictment on insider trading charges related to Australia-based Innate Immunotherapeutics.
Rep. Chris Collins of New York was arrested last week for insider trading in shares of Australia's Innate Immunotherapeutics.
Rep. Christopher Collins was already under investigation for relationship with Australia's Innate Immunotherapeutics.
The company’s algorithms use existing fluoroscopy technology, which captures structures in motion and is commonly used to image the cardiovascular system or direct invasive procedures.
Medibio's technology relies on biometrics (like a person's heart rate and sleep patterns) to gain insight into factors influencing an individual's mental health.